Company intelligence / Profile preview
Jilin Province Baker Pharmaceutical
Meihekou, Jilin, Chinajlbeike.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Jilin Baker Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of anti-viral and anti-infective medications. The company is particularly recognized for its focus on treatments for chronic Hepatitis B and HIV, producing several generic and innovative small molecule drugs. Its product portfolio includes widely used antiviral agents such as Entecavir and Adefovir Dipivoxil. Jilin Baker operates large-scale manufacturing facilities in Jilin Province, adhering to Good Manufacturing Practice (GMP) standards to supply both domestic and international markets.
- Therapeutic areas
- GastroenterologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Jilin Province Baker Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jilin Province Baker Pharmaceutical.